SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-18
👔
Keenova Therapeutics plc
@NONE_InsiderForm 4 Filing: Efron Paul Acquires (Grant) shares of $NONE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Keenova Therapeutics plc
Ticker: $NONE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-15
Shares: 4,406
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Efron Paul, holds the title of Director at Keenova Therapeutics plc.
On 2026-07-15, the insider transacted 4,406 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Efron Paul (Director) was granted $0 of $NONE
Post-Transaction Position: 8,390 shares
SEC Accession No: 0001104659-26-084777 (CIK: 2024711)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.